← SynDRA
ANISINDIONE
SynDRA canonical compound SYN0001532 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | GGCX |
| Mechanism of action | vitamin K antagonist |
| Indication | deep vein thrombosis (DVT) |
| Disease area | hematology |
All known targets
Mechanisms of action (all sources)
- GGCX INHIBITOR
- Vitamin K-dependent gamma-carboxylase inhibitor
- vitamin K antagonist
- F2 MODULATOR
Cross-references
Synonyms
- andion
- miradon
- unidone
- Anisindiona
- NSC-759629
- Miradon
- Anisindionum
- Unidone
- Anisin indandione
- SPE 2792
- Anisindiona [INN-Spanish]
- Anisindione (INN)
- Anisindione [INN:BAN]
- Anisindionum [INN-Latin]
- Miradon (TN)
- 2-(4-Methoxy-phenyl)-indan-1,3-dione
- 2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione
- 2-(4-Methoxyphenyl)indan-1,3-dione
- 2-(4-methoxyphenyl)indene-1,3-dione
- 2-(p-Methoxyphenyl)-1,3-indandione
- 2-(p-Methoxyphenyl)indane-1,3-dione
- 2-[4-(methyloxy)phenyl]-1H-indene-1,3(2H)-dione
- 2-p-Anisyl-1,3-indandione
- 2-para-Anisyl-1,3-indandione
- 1H-Indene-1,3(2H)-dione, 2-(4-methoxyphenyl)-
- S747T1ERAJ
- NSC 759629
- 1,3-Indandione, 2-(p-methoxyphenyl)-
- 1,3-Indanedione, 2-(4-methoxyphenyl)-
- 2-(4-methoxyphenyl)-2,3-dihydro-1H-indene-1,3-dione
- DTXCID102611
- CHEBI:133809
- RefChem:54219
- MFCD00176194
- MLS000554135
- NCGC00094969-01
- SMR000146452
- ANISINDIONE [INN]
Look up ANISINDIONE in the interactive SynDRA portal →